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Abstract 
Background: Different strains of the genus Bacillus are versatile candidates for the industrial production and secretion 
of heterologous proteins. They can be cultivated quite easily, show high growth rates and are usually non-pathogenic 
and free of endo- and exotoxins. They have the ability to secrete proteins with high efficiency into the growth medium, 
which allows cost-effective downstream purification processing. Some of the most interesting and challenging heter-
ologous proteins are recombinant antibodies and antibody fragments. They are important and suitable tools in medical 
research for analytics, diagnostics and therapy. The smallest conventional antibody fragment with high-affinity binding 
to an antigen is the single-chain fragment variable (scFv). Here, different strains of the genus Bacillus were investigated 
using diverse cultivation systems for their suitability to produce and secret a recombinant scFv.
Results: Extracellular production of lysozyme-specific scFv D1.3 was realized by constructing a plasmid with a xylose-
inducible promoter optimized for Bacillus megaterium and the D1.3scFv gene fused to the coding sequence of the 
LipA signal peptide from B. megaterium. Functional scFv was successfully secreted with B. megaterium MS941, Bacillus 
licheniformis MW3 and the three Bacillus subtilis strains 168, DB431 and WB800N differing in the number of produced 
proteases. Starting with shake flasks (150 mL), the bioprocess was scaled down to microtiter plates (1250 µL) as well 
as scaled up to laboratory-scale bioreactors (2 L). The highest extracellular concentration of D1.3 scFv (130 mg L−1) 
and highest space–time-yield (8 mg L−1 h−1) were accomplished with B. subtilis WB800N, a strain deficient in eight 
proteases. These results were reproduced by the production and secretion of a recombinant penicillin G acylase (Pac).
Conclusions: The genus Bacillus provides high potential microbial host systems for the secretion of challenging 
heterologous proteins like antibody fragments and large proteins at high titers. In this study, the highest extracellular 
concentration and space–time-yield of a recombinant antibody fragment for a Gram-positive bacterium so far was 
achieved. The successful interspecies use of the here-designed plasmid originally optimized for B. megaterium was 
demonstrated by two examples, an antibody fragment and a penicillin G acylase in up to five different Bacillus strains.
Keywords: Bacillus megaterium, Bacillus licheniformis, Bacillus subtilis, Antibody fragment D1.3 scFv, Recombinant, 
Secretion, Proteases, Scale-up cultivation, Scale-down cultivation
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Background
Members of the genus Bacillus are rod-shaped aerobic 
or facultatively anaerobic, Gram-positive bacteria [1, 2]. 
This genus is one of the most diverse groups of micro-
organisms and its representatives are widely distributed 
in soil, air and water [1, 2]. Different Bacillus strains 
have been developed and engineered as industrial pro-
ducers of natural enzymes such as alkaline proteases 
(Bacillus clausii), α-amylase (Bacillus licheniformis) and 
β-glucanase (Bacillus subtilis) [3], antibiotics like bacitra-
cin (B. licheniformis) [4], insecticides such as δ-endotoxin 
(Bacillus thuringiensis) [5, 6], vitamin B2 (B. subtilis) 
[7], the supplement poly-γ-glutamic acid or ubiquinone 
biopolymer nanocarriers (B. licheniformis) [8, 9]. Besides 
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natural products, Bacillus strains are great candidates 
for industrial production and secretion of heterologous 
proteins due to several advantages. In comparison to 
eukaryotic systems, their cultivation is simple and their 
high growth rates lead to short cultivation times. Most 
Bacillus strains are non-pathogenic and free of exo- and 
endotoxins. Species like B. subtilis and B. licheniformis 
even have the generally regarded as safe (GRAS) sta-
tus [10, 11]. In addition, these species have the ability to 
secrete proteins directly into the extracellular medium, 
resulting in cost-effective downstream purification pro-
cessing. In contrast, Gram-negative bacteria, like the 
best-analyzed representative Escherichia coli, accumulate 
proteins intracellularly and tend to build mostly cell-toxic 
and insoluble protein accumulations (inclusion bodies). 
These result in cost-intensive downstream processing 
due to incorrect protein folding and inefficient disulfide 
bridge formation [3, 12].
The production of proteins of eukaryotic origin in 
prokaryotic organisms provides one of the biggest chal-
lenges of biotechnology. Eukaryotic proteins heterolo-
gously produced and secreted with Bacillus are e.g. human 
interferon alpha (15 mg L−1, B. subtilis, [13]), growth hor-
mone (200 mg L−1, B. subtilis, [14]) or epidermal growth 
factor (240 mg L−1, Bacillus brevis, [15]). Levels of these 
heterologous proteins are quite low in comparison to 
homologous proteins and those of prokaryotic (Gram-
negative or -positive) origin, e.g. secreted α-amylase with 
up to 3 g L−1 [16]. One major limiting factor is the degra-
dation of the secreted protein by membrane-bound, cell 
wall-associated or secreted proteases [17]. Proteases con-
stitute the cellular quality control which degrade proteins 
folded too slowly or incorrectly [18]. Many heterologous 
proteins are frequently found to be inefficiently and slowly 
folded compared to the homologous counterparts since 
they are not coevolved with the host protein produc-
tion machinery. This might even lead to the exposure of 
protease-recognition sequences even in correctly folded 
conformation [16, 19, 20]. To overcome degradation of 
secreted heterologous proteins, many protease-deficient 
Bacillus mutants have been successfully constructed and 
used resulting in more effective extracellular protein pro-
duction [21].
Some of the most interesting and challenging proteins 
heterologously produced in prokaryotes are recombinant 
antibodies and antibody fragments which are important 
and suitable tools in research and medicine. Their specific 
antigen binding is used in analytics, in proteome research, 
in diagnostics of pathogens and toxins and in therapy of 
inflammatory and tumor diseases [22–24]. A whole immu-
noglobulin G molecule is a hetero-tetramer with two 
heavy and two light chains connected by disulfide bridges 
and intramolecular disulfide bridges for stabilization 
[25]. Since their production requires a complicated fold-
ing apparatus and an oxidizing environment for disulfide 
bridge formation, many microbial host systems fail to pro-
duce significant amounts of the molecules [26]. In addi-
tion, bacterial hosts usually do not accomplish the correct 
glycosylation of the produced antibodies. However, smaller 
and simpler antibody fragments with full antigen bind-
ing capacity have been developed for research purposes, 
where biological activity is more important than structural 
authenticity and correct glycosylation pattern. The small-
est conventional antibody fragment with high-affinity 
binding to an antigen is the single-chain fragment variable 
(scFv) [27], a heterodimer comprising the antibody heavy- 
and light-chain variable domains connected by a peptide 
linker and with natural disulfide bonds within the chains 
to stabilize the molecule [28].
Here, the recombinant production and secretion of 
the lysozyme-specific antibody fragment D1.3 scFv in B. 
megaterium, B. licheniformis and three B. subtilis strains 
differing in their protease equipment are presented to 
demonstrate the interspecies use of the B. megaterium 
plasmid system. For this, the gene encoding His-tagged 
D1.3 scFv genetically fused to a suitable secretion signal 
was expressed under the control of a xylose-inducible 
promoter optimized for recombinant protein production 
in B. megaterium. Starting with uncontrolled shake flask 
(150  mL culture volume) cultivations, the bioprocess 
was scaled down to microtiter plates (1250  µL culture 
volume), but also scaled up to controlled laboratory-scale 
stirred tank bioreactors (2  L culture volume). Growth, 
secretion behavior, product titer, product kinetics and 
space–time-yield (STY) were compared between the 
different strains and cultivation systems. Finally, these 
results were reproduced for the production and the 
secretion of a recombinant penicillin G acylase (Pac) 
with a three times higher molecular weight compared 
to the D1.3 scFv. Pac (EC 3.5.1.11) catalyzes the cleavage 
of penicillin G and cephalosporin G to intermediates 
important for the production of semi-synthetic β-lactam 
antibiotics [29]. It is autocatalytically processed from 
a single cytoplasmic polypeptide precursor carrying a 
signal peptide and a spacer peptide and finally correctly 
folded outside the cell before released to the growth 
medium [30, 31]. Therefore, Pac is a challenging 
candidate for recombinant secretion carried out here 
with three different Bacillus strains using the same 
plasmid background as for the recombinant D1.3 scFv.
Results
Plasmid for the recombinant production and secretion 
of D1.3 scFv
The xylose-inducible promoter PxylA was originally 
derived from the B. megaterium strain DSM319. There it 
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controls the xylABT operon encoding proteins of xylose 
uptake and metabolism via a divergently encoded repres-
sor protein, termed XylR. PxylA was systematically opti-
mized for high yield protein production in B. megaterium 
previously [32]. For the production, secretion and purifi-
cation of D1.3 scFv in B. megaterium, the corresponding 
synthetic gene was fused to the coding sequences for the 
signal peptide of the lipase A of B. megaterium and for 
a his6-tag under control of native PxylA before [33]. The 
employed vector backbone was carrying the oriU, repU 
and tetL genes from the B. cereus plasmid pBC16 [34] for 
replication and selection in Bacillus. To now enhance the 
recombinant production and secretion of D1.3 scFv, the 
D1.3scFv gene fused to the lipase A signal peptide coding 
sequence was cloned into a pBC16-derived plasmid car-
rying the PxylA, optimized for recombinant protein pro-
duction in B. megaterium (Fig. 1). Furthermore, this new 
plasmid pRBBm117 is minimized by around 700  bp to 
reduce metabolic burden for the production strain [35].
After transformation of B. megaterium MS941, a 
mutant of DSM319 lacking the main extracellular pro-
tease NprM and thus around 98% of extracellular pro-
tease activity [36], the recombinant secretion of D1.3 
scFv was analyzed in 150  mL shake flask cultivation in 
minimal medium (Table  1). The oxygen input was real-
ized via orbital shaking movements. The volumetric mass 
transfer coefficients for oxygen (kLa) of 30–50  h−1 were 
assumed [37, 38]. Growth passed the typical phases of 
a batch process (Fig.  2). The addition of 5  g  L−1 xylose 
for the induction of recombinant gene expression 2–3 h 
after inoculation led to temporarily decreased growth. 
The specific growth rate µ [h−1] is the proportionality 
factor between time-dependent change of cell concen-
tration dX/dt [g  L−1  h−1] and current cell concentra-
tion X [g L−1] (dX/dt = µ · X). It decreased from 0.45 to 
0.15  h−1. Growth became accelerated again (0.33  h−1) 
until the initial 5  g  L−1 fructose were completely con-
sumed after 16–18  h. Stationary phase was attained 
with about 2  g  L−1 of cell dry weight. The secretion of 
active, correctly folded D1.3 scFv already started during 
the exponential growth phase while maximal amounts 
of 8  mg  L−1 were detected 4  h after entering the sta-
tionary phase and stayed constant until the end of the 
cultivation. The production was assumed mixed-growth-
associated: the growth-associated biomass-related pro-
duction yield coefficient α  ≡  YP/X  =  0.13  mgscFv g−1cells 
and the non-growth-associated specific production rate 
β  =  0.41  mgscFv g−1cells h
−1 were calculated (Additional 
file  1: Table S1). During stationary phase, the carbon 
source fructose was already depleted and the formerly 
secreted acetate was consumed. The concentration of the 
inducer xylose stayed constant at a level of 5 g L−1 until 
fructose was exhausted and was only slightly reduced to 
>4 g L−1 until the end of the cultivation (Additional file 1: 
Figure S1). Little consumption of xylose by B. megate-
rium MS941 after depletion of the main carbon source 
was described earlier [30] and only slightly influences 
the amount of recombinant protein [39]. Due to the used 
optimized xylose-inducible promoter PxylA the D1.3 scFv 
concentration was found to be around tenfold enhanced 
compared to data published by David et al. [40].
Bioprocess scale‑down and scale‑up
Next, the culture volume was either reduced to 1250 μL 
or increased to 2 L (Table 1). While miniaturization from 
mL to µL scale using microtiter plates is advantageous 
pRBBm117
7306 bp
bla (E. coli)
xylR
tetL
repU (pBC16)
signal peptide splipA
his6-tag
D1.3scFv
PxylAopt. opt. RBS
ori (pBR322)
oriU (pBC16)
Fig. 1 Plasmid pRBBm117 for recombinant production of the anti-
body fragment D1.3 scFv. PxylA
opt., optimized xylose-inducible promoter; 
opt. RBS, optimized ribosome binding site; splipA, signal peptide 
sequence of B. megaterium extracellular esterase LipA; D1.3scFv, gene 
for single chain fragment variable (scFv) against lysozyme; his6-tag, 
synthetic tag for 6× histidine residues; bla, β-lactamase gene for 
ampicillin resistance; ori (pBR322), E. coli origin of replication from 
plasmid pBR322; oriU (pBC16), B. megaterium origin of replication 
from plasmid pBC16; repU (pBC16), gene essential for plasmid 
replication in B. megaterium from plasmid pBC16; tetL, gene encoding 
tetracycline efflux pump for tetracycline resistance; xylR, gene encod-
ing xylose repressor
Table 1 Summary of  cultivation conditions in  microtiter 
plates, shake flasks and bioreactors
a 3 mm orbital diameter
b 50 mm orbital diameter
c Before addition of anti-foaming agent
Parameter Microtiter plate Shake flask Bioreactor
Cultivation volume [mL] 1.25 150 2000
Shake/stirrer frequency 
[min−1]
1000a 130b 500
Aeration rate [L min−1] 
with air
– – 3
kLa value [h
−1] 150–200 30–50 75–85c
pH value [–] Unregulated Unregulated 6.5
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for processing a large number of parallel experiments, 
lab-scale stirred tank bioreactors provide more opportu-
nities for online measuring and controlling various cul-
tivation parameters. One of the important parameters 
in this study was the oxygen supply. For shake flasks and 
microtiter plates, oxygen input was realized via orbital 
shaking movements. As the ratio of gas–liquid exchange 
area to liquid volume strongly increased in microti-
ter plates compared to that provided in the shake flasks 
[41], a higher oxygen transfer rate (OTR) with kLa values 
of 150–200  h−1 was obtained. For stirred tank bioreac-
tors, oxygen input was ensured via direct air inflow and 
agitation and kLa values of 75–85  h−1 were measured. 
However, addition of 15 mg L−1 anti-foaming agent after 
around 9 h of cultivation was necessary in bioreactor cul-
tivations. Anti-foaming agents usually decreases oxygen 
transfer due to coalescence of bubbles and by retarding 
surface flow at the gas liquid interface [42, 43]. The DO 
dropped to nearly 0% and a sudden rise of dissolved oxy-
gen (DO) to 80% marked the transition to the station-
ary phase in the bioreactor cultivations (Fig.  3). In the 
microtiter plates, the DO declined to only 40% due to 
better oxygen transfer. Lower oxygen tension slowed the 
energy generation of the respiratory chain and the pre-
sent fructose concentration caused overflow metabolism 
[44], indicated by the secretion of acetate during growth 
(Fig.  2 and Additional file  1: Figure S1) which has been 
described previously [40, 45]. In this study, maximal 
acetate concentrations of 0.45–0.55  g  L−1 were attained 
in shake flask and bioreactor cultivations, but only 
0.25  g  L−1 in microtiter plate experiments. Acetate as 
non-preferential substrate was re-utilized after fructose 
depletion in shake flasks and microtiter plates. Finally, the 
oxygen availability also influences the amount of recom-
binant D1.3 scFv produced (Fig. 3). While in the bioreac-
tor the production profile of D1.3 scFv was found to be 
very similar to that in shake flasks with maximal concen-
trations of 8 mg L−1 after 22–23 h of cultivation, in micr-
otiter plates higher concentrations of up to 15  mg  L−1 
were reached already after 17–18 h. As the product was 
secreted in both growth and stationary phase, secretion 
was assumed to be mixed-growth-associated or slightly 
growth-independent with α  =  0.28  mgscFv g−1cells and 
β = 0.79 mgscFv g−1cells h
−1 for microtiter plate cultivations 
and α  =  0 mgscFv g−1cells and β  =  0.31 mgscFv g−1cells h
−1 for 
bioreactor experiments (Additional file 1: Table S1). The 
amount of active antibody fragment remained constant 
also in late stationary phase or even further increased 
during microtiter plate cultivation (Figs. 2, 3) indicating a 
stable product form.
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Fig. 2 Cultivation profile of recombinant B. megaterium MS941 secreting D1.3 scFv in shake flasks. B. megaterium MS941 was transformed with 
plasmid pRBBm117 (PxylA
opt.-splipA-d1.3scFv-his6). Cultivation took place in baffled shake flasks (150 mL culture volume) under aerobic conditions at 
37 °C. Cultures were inoculated with cell concentrations (cell dry weight) of 0.0223 g L−1 in minimal medium containing 10 mg L−1 of tetracycline. 
Recombinant D1.3 scFv secretion was induced by the addition of 5 g L−1 of xylose at cell concentrations of around 0.07 g L−1. Samples were taken 
at given time points to analyze cell dry weight [g L−1], extracellular concentrations of D1.3 scFv [mg L−1] using ELISA and of fructose, xylose and 
acetate using HPLC
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Production of recombinant D1.3 scFv using B. licheniformis
Xylose-inducible gene expression can also be found in B. 
licheniformis [46] indicating its ability to take up xylose 
present in the medium. Hence, the plasmid pRBBm117 
constructed for recombinant xylose-dependent D1.3 
scFv secretion in B. megaterium was introduced into 
B. licheniformis strain MW3 [47]. Strain MW3 is a 
restriction-negative mutant of the type strain DSM13 in 
which two type I restriction modification systems were 
destructed enabling a better transformation and higher 
stability of foreign DNA compared to the wild type [47].
The growth behavior of recombinant B. licheniformis 
MW3 (Fig. 4) was similar for all three cultivation systems 
with maximal specific growth rates of 0.34–0.42 h−1. In 
contrast to recombinant B. megaterium, growth was 
not notably reduced after addition of the inducer xylose 
4–5  h after inoculation. In all three systems, fructose 
was consumed after 12–14  h and stationary phase was 
reached with about 1.5–2.0 g L−1 of cell dry weight. Less 
maximal biomass was formed compared to recombinant 
B. megaterium MS941.
In the bioreactor cultivation, DO decreased to 
nearly 0% at the end of the exponential growth phase 
(Additional file 1: Figure S2) implying oxygen limitation 
although fructose was still available. In microtiter plates, 
better oxygen transfer resulted in a less strongly decrease 
of DO to 50–60%. As for recombinant B. megaterium, 
this was accompanied by the secretion of the overflow 
metabolite acetate. Maximal acetate concentrations 
of 0.7  g  L−1 were detected in bioreactors, but only 
0.4  g  L−1 in shake flaks and microtiter plates when the 
culture reached the stationary phase. Re-utilization of 
the secreted acetate as well as partly metabolization of 
xylose explains the slight biomass increase after fructose 
depletion in bioreactors and microtiter plates. Secretion 
and re-utilization of acetate [48] and the utilization of 
xylose as carbon source [49] were described previously.
Although growth was not affected by the addi-
tion of the inducer, slightly higher amounts of 
recombinant functional D1.3 scFv were secreted by 
recombinant B. licheniformis compared to B.  megate-
rium. Highest product amounts were again reached 
in microtiter plates (17  mg  L−1 after 18  h), followed 
by shake flasks (15  mg  L−1 after 15  h) and bioreac-
tor cultivations (13 mg L−1 after 18 h). Secretion seems 
to be non-growth-associated in microtiter plates 
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Fig. 3 Cultivation profile of recombinant B. megaterium MS941 secreting D1.3 scFv in microtiter plates and bioreactors. B. megaterium MS941 was 
transformed with plasmid pRBBm117 (PxylA
opt.-splipA-d1.3scFv-his6). Cultivation took place in microtiter plates (1250 μL culture volume) and stirred tank 
bioreactors (2 L culture volume) under aerobic conditions at 37 °C. All cultivation systems were inoculated with cell concentrations (cell dry weight) 
of 0.0223 g L−1 in minimal medium containing 10 mg L−1 of tetracycline. Recombinant D1.3 scFv secretion was induced by the addition of 5 g L−1 
of xylose at cell concentrations of around 0.07 g L−1. Samples were taken at given time points to analyze cell dry weight [g L−1] and extracellular 
concentration of D1.3 scFv [mg L−1] using ELISA. Dissolved oxygen was measured online. Further analyses are shown in Additional file 1: Figure S1
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(α = 0 mgscFv g−1cells and β = 1.19 mgscFv g−1cells h
−1) and bio-
reactors (α = 0 mgscFv g−1cells and β = 0.51 mgscFv g−1cells h
−1) 
as occurring mainly in the stationary phase (Addi-
tional file  1: Table S1). For shake flask cultivation, 
mixed-growth-associated secretion was observed with 
α  =  3.286  mgscFv g−1cells and β  =  1.286  mgscFv g−1cells h
−1 
(Additional file 1: Table S1). For cultivations in microtiter 
plates and shake flasks, extracellular scFv concentration 
decreases during stationary phase. Since B. licheniformis 
DSM13, the wild type strain of the here-used derivate 
MW3, is known to produce various extracellular pro-
teases including well-studied Subtilisin Carlsberg [50], 
degradation of scFv by these enzymes is assumed.
Influence of genome‑encoded proteases on the amount 
of secreted D1.3 scFv in recombinant B. subtilis
Next, three different B. subtilis strains, 168 [51], DB431 
[52] and WB800N [53, 54], were individually transformed 
with the production plasmid pRBBm117. The three 
B. subtilis strains differ in their gene sets for intra- and 
extracellular proteases what should strongly influence 
the stability of recombinant D1.3 scFv inside and outside 
of the cell. Compared to the wild type strain B. subtilis 
168, B. subtilis strain DB431 is deficient in four extracel-
lular [subtilisin E (AprE), neural metalloprotease (Npr), 
minor extracellular protease (Epr), extracellular metal-
loprotease (Mpr)] and two intracellular proteases [the 
major intracellular serine protease (IspA) and bacillo-
peptidase F (Bpr)] [52, 55]. B. subtilis strain WB800N is 
also a derivative of strain 168 and lacks six extracellular 
proteases namely subtilisin E (AprE), neural protease B 
(NprB), bacillolysin (NprE), two minor extracellular pro-
teases (Epr and Vpr) and metalloprotease (Mpr) as well as 
a cell wall-associated protease (WprA) and intracellular 
bacillopeptidase F (Bpr) [53–55].
Since B. subtilis was described to ineffectively utilize 
xylose as carbon source due to a missing specific trans-
port system [56], the suitability of the here used and opti-
mized xylose-inducible plasmid system had to be tested 
for the used strains. For this purpose, extracellular pre-
cipitated proteins were compared after xylose-induced 
and non-induced cultivations after 13–15  h in shake 
flasks via SDS-PAGE. In the medium of all three B. subti-
lis strains the antibody fragment D1.3 scFv, a monomeric 
protein with a molecular weight of approximately 27 kDa, 
was clearly observed for induced, but only marginally 
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Fig. 4 Cultivation profile of recombinant B. licheniformis MW3 secreting D1.3 scFv. B. licheniformis MW3 was transformed with plasmid pRBBm117 
(PxylA
opt.-splipA-d1.3scFv-his6). Cultivation took place in microtiter plates (1250 μL culture volume), baffled shake flasks (150 mL of culture volume) and 
stirred tank bioreactors (2 L of culture volume) under aerobic conditions at 37 °C. All cultivation systems were inoculated with cell concentrations 
(cell dry weight) of 0.04 g L−1 in minimal medium containing 10 mg L−1 of tetracycline. Recombinant D1.3 scFv secretion was induced by the addi-
tion of 5 g L−1 of xylose at cell concentrations of around 0.12 g L−1. Samples were taken at given time points to analyze cell dry weight [g L−1] and 
extracellular concentrations of D1.3 scFv [mg L−1] using ELISA. Further analyses are shown in Additional file 1: Figure S2
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for non-induced cultivations (Fig. 5a). This indicated the 
enhanced production and secretion of D1.3 scFv in the 
presence of xylose and confirmed the correct function of 
the here used xylose-inducible promoter system. At the 
same time, the used plasmid system revealed a high segre-
gational stability in the here tested B. subtilis strains. The 
application of the xylose-inducible promoter in B. subtilis 
was described previously but was only tested as genomi-
cally integrated system due to plasmid instabilities [57]. 
In addition, the amount of secreted D1.3 scFv positively 
correlated with the number of eliminated proteases. B. 
subtilis WB800N showed the highest and B. subtilis 168 
the lowest concentration of D1.3 scFv (Fig. 5b). Although 
B. megaterium strain MS941 showed a very low pro-
tease activity [36], there was only very low extracellu-
lar overall protein and corresponding very low amount 
of extracellular D1.3 scFv visible compared to WB800N 
(Fig. 5b).
Production and secretion of recombinant penicillin G 
acylase in different Bacillus strains
To verify obtained results for the recombinant production 
of D1.3 scFv similar experiments were performed for the 
recombinant production of the exo-enzyme penicillin G 
acylase (Pac) using B. megaterium MS941, B. subtilis 168 
and B. subtilis WB800N. Pac consists of a small α subunit 
(27 kDa) and a large β subunit (59 kDa) which are autocat-
alytically processed from a cytoplasmic polypeptide pre-
cursor and folded outside the cell after secretion [30, 31]. 
For recombinant production of Pac in different Bacillus 
strains, the expression plasmid pALBm1 was constructed, 
which encodes the Pac protein from B. megaterium 
ATCC14945 with its original signal peptide. Transcription 
of the corresponding gene is controlled by the optimized 
xylose-inducible promoter system. All other structures of 
pALBm1 are identical to these of the plasmid pRBBm117 
used for antibody fragment production. Cultivations of 
transformed B. megaterium MS941 as well as B. subtilis 
168 and WB800N were performed in shake flasks with 
150 mL of LB medium at 37 °C.
Growth was similar for all investigated strains. All 
strains reached the stationary phase after 21  h with 
cell dry weights of about 2  g  L−1 (Fig.  6). Production 
of active recombinant protein was demonstrated for 
all tested strains. Maximal extracellular Pac activi-
ties of 0.4  U  mL−1 (24–32  h), 0.3  U  mL−1 (18  h) and 
0.65 U mL−1 (24–32 h) were detected for B. megaterium 
MS941, B. subtilis 168 and B. subtilis WB800N, respec-
tively. Maximal Pac activities were observed after longer 
cultivation times compared to those required for maxi-
mal concentrations of D1.3 scFv. Here again B.  subtilis 
168 reached maximal product amount earlier compared 
to B. megaterium MS941 and B. subtilis WB800N (Fig. 6). 
The lowest Pac activities of 0.3  U  mL−1 were observed 
with B. subtilis 168, which were even lower than with 
B. megaterium MS941 (0.4  U  mL−1), probably showing 
the influence of highly active proteases, while the lack of 
eight proteases characterizing B. subtilis WB800N dou-
bled the maximal activity to 0.65 U mL−1. The observed 
production and secretion behavior for Pac was similar for 
all tested strains compared to the antibody fragment pro-
duction and secretion.
Time‑resolved comparison of recombinant D1.3 scFv 
secretion in different B. subtilis strains
Next, B. subtilis strains 168, DB431 and WB800N all 
transformed with pRBBm117 were individually cultivated 
in microtiter plates, shake flasks, and bioreactors (Table 1) 
investigating time-resolved growth behavior and secretion 
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32 kDa
D1.3 scFv
25 kDa
22 kDa
32 kDa
D1.3 scFv 
25 kDa
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Xyl+       Xyl- Xyl+     Xyl- Xyl+     Xyl-
M             168                     DB431                WB800N
b
a
Fig. 5 Secretion of D1.3 scFv and other extracellular proteins by 
recombinant Bacillus strains. Extracellular proteins of 188 µL culture 
supernatant from shake flasks were precipitated and analyzed by 
SDS-PAGE. a Extracellular proteins of B. subtilis strains 168, DB431 
and WB800N were analyzed by SDS-PAGE after 13–15 h of cultiva-
tion. Xylose-induced (Xyl+) and non-induced (Xyl−) cultures were 
compared with a protein standard (marker M). Only the proteins with 
a size between 25 and 32 kDa are shown. b Extracellular proteins of 
induced B. megaterium MS941 (22 h) and B. subtilis 168, DB431 and 
WB800N (13–15 h) were precipitated and analyzed by SDS-PAGE 
compared with a protein standard (marker M)
http://publikationsserver.tu-braunschweig.de/get/64222
Page 8 of 18Lakowitz et al. Microb Cell Fact  (2017) 16:14 
of D1.3 scFv. Recombinant B. subtilis 168 and B. subtilis 
DB431 grew faster with maximal specific growth rates of 
0.42–0.53 h−1 in all three cultivation systems compared to 
recombinant B. megaterium and B. licheniformis (Addi-
tional file 1: Figure S3). Recombinant D1.3 scFv produc-
tion and secretion was induced after 2.5–3.5 h, resulting 
in decreased specific growth rates of 0.16–0.27 h−1 until 
reaching 0.34–0.49  h−1 again about 4–6  h after induc-
tion. Stationary phase was already reached after 10–12 h 
with maximal cell dry weights of 1.5–2.0  g  L−1. In con-
trast, growth of recombinant B.  subtilis strain WB800N 
was slower (0.36–0.41  h−1). Also, induction of recombi-
nant scFv secretion after 3.0–3.5 h of growth resulted in 
less decreased growth rate (0.22–0.29  h−1). Stationary 
phase was reached after 12–14 h, but lower maximal cell 
dry weights of 1.0–1.3 g L−1 were detected compared to 
the other two B. subtilis strains. During stationary phase, 
xylose was partly metabolized (1.0–2.5 g L−1) by all three 
B. subtilis strains after depletion of fructose (Additional 
file 1: Figures S4–S6), again indicating an efficient uptake 
of the sugar.
Cultivating B. subtilis strains in bioreactor, signifi-
cant foam formation was fought by addition of overall 
30  mg  L−1 (168), 50  mg  L−1 (DB431) and 100  mg  L−1 
(WB800N) of anti-foaming agent. The observed amount 
of foam can be explained by the high amount of extra-
cellular proteins known to encourage foam formation 
[58] (Fig. 5b). The DO dropped to 0% 3 h (168) and 2 h 
(DB431) prior transition to stationary phase (Additional 
file 1: Figures S4, S5). Due to slower growth for WB800N, 
the DO of this strain only dropped down to 20% about 
2  h before transition to stationary phase (Additional 
file  1: Figure S6) since a lower OTR into the cells was 
needed. The observed oxygen limitation in bioreactor 
cultivations resulted in the secretion of the fermenta-
tion product acetate in high amounts of 0.6 g L−1 (168), 
0.7 g L−1 (DB431) and 0.9 g L−1 (WB800N) (Additional 
file1: Figures S4–S6). In contrast to that, culture volume 
reduction realized higher OTR and minimal DO values 
of 20–50% (168), 40% (DB431) and 80% (WB800N) in 
microtiter plates resulting in lower amounts of secreted 
acetate [0.1 g L−1 (168), 0.3–0.4 g L−1 (DB431), 0.7 g L−1 
(WB800N)] compared to bioreactor cultivations. For all 
B. subtilis strains and cultivation systems, maximal ace-
tate concentrations occurred simultaneously at transi-
tion to stationary phase. Finally, strains 168 and DB431 
re-utilized secreted acetate completely in the stationary 
phase, resulting in another decline of DO in the bioreac-
tors, but due to low concentrations of acetate this was 
not the case in microtiter plates (Additional file 1: Figures 
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Fig. 6 Time-dependency of cell dry weight and penicillin G acylase activity for cultivation of recombinant Bacillus strains. Cultivation took place in 
baffled shake flasks (150 mL culture volume) under aerobic conditions at 37 °C in LB medium containing 10 mg L−1 of tetracycline. Samples were 
taken at given time points to analyze cell dry weight [g L−1] and activity of penicillin G acylase [U mL−1] via enzymatic assay
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S4, S5). Strain WB800N only partly metabolized the ace-
tate in the growth medium (Additional file 1: Figure S6). 
Secretion and re-utilization of acetate was described pre-
viously for another B. subtilis strain [59].
Biologically active D1.3 scFv was secreted with all 
three recombinant B. subtilis strains in all three cul-
tivation systems (Figs.  7, 8). Secretion was observed 
to be strongly (168) or mainly (DB431 and WB800N) 
growth-associated, since maximal concentrations were 
observed during or shortly after transition into sta-
tionary phase, respectively (Additional file 1: Table S1). 
Growth-associated secretion of a scFv with B. subtilis 
was described earlier with much lower product con-
centration although using a protease deficient strain 
[60]. In this study, maximal formed and secreted D1.3 
scFv concentrations significantly differed depending 
on the used B. subtilis strain and the employed culti-
vation system. Maximal D1.3 scFv amounts in shake 
flasks were 30  mg  L−1 (168, after 12–13  h), 50  mg  L−1 
(DB431, after 14  h) and 120  mg  L−1 (WB800N, after 
16–18  h), respectively, while for B. subtilis DB431 and 
WB800N, slightly higher concentrations were observed 
in microtiter plates (60 and 130  mg  L−1) due to better 
OTRs. For bioreactors, lower maximal D1.3 scFv con-
centration of 20 mg L−1 (168), 30 mg L−1 (DB431) and 
70  mg  L−1 (WB800N) were obtained, which might be 
due to the limited supply of oxygen or a negative effect 
of the added anti-foaming agent on product formation 
or secretion [61]. Compared to B. megaterium MS941 
and B. licheniformis MW3, higher D1.3 scFv concen-
trations were achieved in less cultivation time with all 
three B. subtilis strains.
Fig. 7 Maximal extracellular D1.3 scFv concentrations for recombinant B. subtilis 168, DB431 and WB800N. B. subtilis strains were transformed with 
plasmid pRBBm117 (PxylA
opt.-splipA-d1.3scFv-his6). Cultivation took place in microtiter plates (1250 μL culture volume), baffled shake flasks (150 mL 
culture volume) and stirred tank bioreactors (2 L culture volume) under aerobic conditions at 37 °C. All cultivation systems were inoculated with 
cell concentrations (cell dry weight) of 0.0337 g L−1 in minimal medium containing 10 mg L−1 of tetracycline. Recombinant D1.3 scFv secretion 
was induced by the addition of 5 g L−1 of xylose at cell concentrations of around 0.10 g L−1. Extracellular concentration of D1.3 scFv [mg L−1] for B. 
subtilis 168, DB431 and WB800N was analyzed using ELISA. Further analyses are shown in Additional file 1: Figures S3–S6
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Bacillus subtilis 168 did not only secrete the smallest 
amount of D1.3 scFv among the examined B. subtilis 
strains but its extracellular scFv concentration also 
strongly decreased during stationary phase for 
all cultivation systems. Especially in stirred tank 
bioreactors, scFv concentration dropped dramatically 
fast in stationary phase of cultivation, resulting in a 
quite narrow and small concentration profile. Here, 
degradation by proteases was strongly assumed, since 
B. subtilis 168 is known to produce and secrete high 
amounts of different proteases, especially at the end 
of growth phase [62]. Apparently, the absence of six 
proteases in B. subtilis DB431 resulted in higher and 
more constant scFv titer profiles, although degradation 
of scFv during stationary phase still occurred (Fig.  8). 
Finally, B. subtilis WB800N, lacking eight proteases, 
secreted the highest scFv amounts for all three 
cultivation systems and no significant degradation 
of scFv occurred in any cultivation system during 
stationary phase clearly indicating the positive influence 
of proteases deficiency on the recombinant protein 
production and secretion in this B. subtilis strain.
Space–time‑yield (STY) of D1.3 scFv secretion in Bacillus
For overall balancing and evaluation of the production 
and secretion of D1.3 scFv, the space–time-yield (STY) 
was calculated as the proportion of scFv concentration 
and corresponding cultivation time (Fig. 9). For recom-
binant B. megaterium, STY of about 0.35  mg  L−1  h−1 
for shake flasks and bioreactors and of 0.62 mg L−1 h−1 
for microtiter plates were attained. With recombi-
nant B. licheniformis, higher values of 1.01, 0.77 and 
0.91 mg L−1 h−1 were observed. STY for recombinant B. 
subtilis were much higher. Here again, values increased 
from strain 168 over DB431 to WB800N. Cultivation in 
stirred tank bioreactors resulted in the lowest STY (1.8, 
2.5 and 4.1 mg L−1 h−1) despite the short correspond-
ing cultivation time. In microtiter plates, the highest 
values of 2.8, 5.4 and 8.0 mg L−1 h−1 were reached, even 
though these for shake flasks were only slightly lower 
(2.1, 3.6 and 7.0  mg  L−1  h−1). The highest STY was 
reached with B. subtilis WB800N for all three cultiva-
tion systems. These STYs were about 15 times higher 
than that of the recombinant reference strain B. mega-
terium MS941.
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Fig. 8 Time-dependent extracellular concentration of D1.3 scFv for the recombinant B. subtilis 168, DB431 and WB800N. Cultivation took place 
in microtiter plates (1250 µL culture volume), baffled shake flasks (150 mL of culture volume) and bioreactors (2 L culture volume) under aerobic 
conditions at 37 °C. All cultivation systems were inoculated with cell concentrations (cell dry weight) of 0.0337 g L−1 in minimal medium contain-
ing 10 mg L−1 of tetracycline. Recombinant D1.3 scFv secretion was induced by the addition of 5 g L−1 of xylose at cell concentrations of around 
0.07 g L−1. Samples were taken at given time points to analyze extracellular concentration of D1.3 scFv [mg L−1] for B. subtilis 168, DB431 and 
WB800N using ELISA
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Discussion
In this study, different strains of the genus Bacillus were 
shown to efficiently produce and secrete the recombinant 
antibody fragment D1.3 scFv as well as penicillin G 
acylase Pac in three different cultivation systems. For 
this, all strains were successfully transformed with 
the identical plasmid encoding D1.3 scFv and Pac, 
respectively, together with an optimized B. megaterium 
xylose-inducible promoter system and B. megaterium 
originated signal peptides [63]. This clearly shows the 
broad interspecies application of an expression plasmid 
in Bacillus, which was not investigated so far.
Production and secretion of scFvs and scFabs with 
B. megaterium were examined before using its native 
xylose-inducible promoter system. With this system, 
390  µg  L−1 of anti-CRP scFv [64], 410  µg  L−1 of D1.3 
scFv [33] and 3.5  µg  L−1 of the more complex D1.3 
scFab were produced and secreted in their active forms 
by B. megaterium strain MS941 [64] deficient in the 
main extracellular protease NprM lacking around 
98% of the overall extracellular protease activity [36]. 
When compared to the production and secretion by 
a B. megaterium strain additionally deficient in xylose 
metabolization [30], D1.3 scFv secretion was enhanced 
to 700 µg L−1 in shake flasks and even 3 mg L−1 in 3 L 
bioreactors [40, 65]. With E. coli, about 1–2  mg  L−1 of 
D.13 scFv were recovered as soluble protein in the culture 
supernatant and as periplasmic fraction [66], showing the 
inefficient production in Gram-negative bacteria.
For B. licheniformis, no secretion of any scFv was 
described so far. For the here-used strain B. licheniformis 
MW3, scFv concentrations in the same range as for 
B. megaterium were achieved. Among the tested B. 
subtilis strains, highest amounts of active D1.3 scFv 
were secreted with the strain WB800N deficient in eight 
proteases. WB800N showed the highest product yield 
which was 8.7-fold higher than the best B. megaterium 
MS941 cultivation and 4.3- and 2.2-fold higher than for B. 
subtilis strains 168 and DB431, respectively. Deficiencies 
of aprE, npr, epr, mpr, ispA and bpr of B. subtilis DB431 
lead to doubling of scFv concentration (up to 60 mg L−1) 
compared to B. subtilis 168 (up to 30 mg L−1). Additional 
deficiency in nprB, vpr and wprA in B. subtilis WB800N 
resulted in another doubling of scFv concentration (up to 
130  mg  L−1). This is the highest level of a recombinant 
antibody fragment for a Gram-positive bacterium 
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described so far. In the literature, B. subtilis strains, 
mostly mutants of strain 168 with deletions of one or 
more protease genes, show very low overall extracellular 
protease activity leading to improved yields of various 
products compared to the wild type strain [21]. Secretion 
of up to 15 mg L−1 with B. subtilis was described before 
[53, 60, 67]. The three-protease-deficient B. subtilis 
WB30 was reported to secrete 3.5  mg  L−1 and the six-
protease-deficient WB600 5  mg  L−1 of an scFv against 
digoxin [60]. With coproduction of intracellular and 
extracytoplasmic molecular chaperones, scFv titers 
of 12  mg  L−1 were observed [67]. With B. subtilis 
WB700N, a seven-extracellular-protease-deficient 
derivate, secretion of scFv against fibrin even failed [53]. 
However, the combination of enhanced coproduction 
of molecular chaperones and additional inactivation 
of the cell-wall-associated protease WprA in the strain 
WB800HM[pEPP] resulted in scFv titers of up to 
15  mg  L−1 [53]. In addition, correlation of increased 
stability of the produced scFv with less secreted proteases 
was observed comparing B. subtilis 168, WB30 and 
WB600 [60]. In accordance with that, in this study higher 
and more constant scFv titer profiles were observed 
for the protease-deficient B. subtilis strains DB431 and 
WB800N.
Apart from B. megaterium and B. subtilis, production 
of extracellular recombinant antibody fragments has 
been reported only for B. brevis and Lactobacillus  spp. 
With B.  brevis, secretion of about 100  mg  L−1 of a Fab 
against human urokinase-type plasminogen activator 
was reported [68]. Lactobacillus spp. were used to secrete 
6 µg L−1 of Guy’s 13 scFv against a streptococcal adhesion 
molecule [69], 410  µg  L−1 of codon-optimized antiviral 
3D8 scFv [70] and 1 mg L−1 of an of llama heavy-chain 
(VHH) antibody fragment against rotavirus [71].
In contrast to Bacillus-based production systems 
mammalian cell cultures produce antibodies at g  L−1 
scale. However, much longer cultivation times of up 
to 3  weeks are needed. For example, using a human 
cell line 400–500  mg  L−1 of IgG were produced within 
10 days, corresponding to a STY of 1.66–2.08 mg L−1 h−1 
[72]. IgG concentrations of 2.64 g L−1 (in 13 days) were 
realized with NSO cells, which corresponds to a STY of 
8.46 mg L−1 h−1 [73]. For CHO cells up to 12.8 mg L−1 h−1 
of IgG were described [74–76]. Since we observed 
maximal secretion with the tested Bacillus strains in 
only 9–21  h, the resulting STY of up to 8  mg  L−1  h−1 
are in the same order of magnitude as described for 
mammalian cells, showing the ability to compete with 
these cultivation systems for scFv-secretion. However, 
cultivation costs are characteristically smaller for the 
bacterial production systems.
Recombinant production of penicillin G acylase Pac 
from B. megaterium ATCC14945 in other B. megate-
rium [30] and B. subtilis [77–79] strains was shown pre-
viously, using various cultivation systems and mainly 
complex media. Here, we used the production of this 
enzyme for the confirmation of the results obtained for 
scFv-production and secretion. In agreement, the defi-
ciency for eight proteases in B. subtilis WB800N led to 
a doubling of the maximal activity while the presence of 
all natural protease clearly reduced the amount of Pac in 
the medium, validating the assumptions made for D1.3 
scFv production in protease-deficient B. subtilis strains. 
Overall, similar results were obtained in comparison to 
the recombinant secretion of D1.3 scFv, clearly confirm-
ing the general applicability of the introduced systems.
Conclusions
Different tested strains of the genus Bacillus provided 
high potential microbial production systems to synthesize 
and export challenging heterologous proteins like 
antibody fragments and high molecular weight proteins 
at high titers in different cultivation systems: a microtiter 
plate approach (1250  μL culture volume), uncontrolled 
shake flasks (150  mL culture volume) and a controlled 
laboratory-scale stirred tank bioreactor (2  L culture 
volume). The employed plasmid originally optimized for 
the recombinant protein production in B. megaterium 
can also efficiently be used for B. licheniformis and B. 
subtilis strains, which demonstrates its interspecies 
application. Kinetics of D1.3 scFv production were 
successfully described with the Luedeking–Piret model 
for all tested Bacillus strains and cultivation systems. 
Highest production and secretion of the antibody 
fragment was attained in microtiter plates and shake flask 
because of their better oxygen transfer compared to the 
stirred tank bioreactor approach. B. subtilis WB800N, 
deficient in eight proteases, secreted 130  mg  L−1 (STY 
of 8 mg L−1 h−1) of the recombinant antibody fragment 
D1.3 scFv, which is the highest concentration and 
STY of a recombinant antibody fragment for a Gram-
positive bacterium described so far. Finally, interspecies 
application of the plasmid system were also shown for 
the secretion of a recombinant heterodimeric protein, 
the penicillin G acylase Pac.
Methods
Strains and plasmids
All strains and plasmids used in this study are listed in 
Table  2. For cloning procedures, E. coli strain DH10B 
acted as host (Life Technologies, Carlsbad, USA). B. mega-
terium strain MS941 is a derivate of the wild type strain 
DSM319 with a defined deletion in the gene encoding 
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the major extracellular protease NprM [36, 80]. B licheni-
formis strain MW3, a derivate of the type strain DSM13, 
has defined deletions in genes encoding two type I restric-
tion modification systems (HsdR1, HsdR2) to improve 
transformability and recombinant DNA stability [47]. B. 
subtilis 168, the most widely biotechnologically used B. 
subtilis strain, is originated from B. subtilis Marburg via 
X-ray-mutagenesis. It is tryptophan-requiring auxotroph 
[51]. B. subtilis strain DB431 is deficient in four extracel-
lular and two intracellular proteases [52], while strain 
WB800N lacks six extracellular, one cell-wall-associated 
and one intracellular protease [53, 54]. For generation of 
the here used expression plasmid pRBBm117, the D1.3scFv 
gene fused to the coding sequences of the signal peptide of 
the B. megaterium lipase A [63] at its 5′-end, of a His6-tag 
at its 3′-end and of a terminator structure were liberated 
from plasmid pEJBmD1.3scFv [33] using the restriction 
enzymes BsrGI and AgeI. The fragment was cloned into 
similarly cut p3STOP1623hp [32] resulting in pRBBm117. 
For generation of expression plasmid pALBm1, the pac 
gene encoding the penicillin G acylase was amplified from 
genomic DNA of B. megaterium ATCC14945 using the 
primers pac_fw (5′-TACATATGTACAATGAAGACGAA-
GTGGCTAATATCA-3′) and pac_rv (5′-TATCAGAGCT-
CATCAATAGTATAGGCTC-3′). The pac gene including 
the native signal peptide was cloned into the shuttle vector 
p3STOP1623hp [32] using SacI und BsrGI.
Isolation of genomic DNA from B. megaterium ATCC14945
For preparation of chromosomal DNA from B. 
megaterium ATCC14945, the JETquick Plasmid Miniprep 
Kit (Genomed, Löhne, Germany) was used according to 
the manufacturer’s instructions with some modifications. 
Cells from a cryogenic glycerol stock were grown 
overnight at 37 °C and 130 min−1 in 50 mL of LB medium 
in baffled flasks. Cells of 6  mL culture suspension were 
harvested and suspended in 250  µL TE(H) buffer 
(150 mM Tris–HCl, 20 mM EDTA, pH 8) before 20 µL 
of lysozyme solution (20 g L−1 lysozyme in TE(H) buffer) 
were added. Cells were incubated for 10 min at 37 °C and 
750 min−1 before adding the next buffer. Before elution of 
DNA, the column was washed with 500 mL of GX buffer 
and 500 µL of G4 buffer.
Transformation and strain maintenance
Unless mentioned here, molecular biology methods used 
in this study were described previously [81]. Plasmid 
DNA for the transformation of B. megaterium MS941, 
B. licheniformis MW3 and B. subtilis 168 was pre-
pared from recombinant E. coli while plasmid DNA for 
Table 2 Strains and plasmids used in this study
Strain or plasmid Description Reference/source
Escherichia coli DH10B F− endA1 deoR+ recA1 galU galK16 nupG rpsL Δ(lac)X74 
φ80lacZΔM15 araD139 Δ(ara, leu)7697 mcrA Δ(mrr-
hsdRMS-mcrBC) StrR λ−
Invitrogen, Carlsbad, USA
Bacillus megaterium MS941 Bacillus megaterium DSM319 ΔnprM [36]
Bacillus megaterium ATCC14945 Produces penicillin G acylase American Type Culture Collection; Manassas, Virginia; USA
Bacillus licheniformis MW3 Bacillus licheniformis DSM13 (ΔhsdR1, ΔhsdR2) [47]
Bacillus subtilis 168 trpC2 [51]
Bacillus subtilis DB431 trpC2 nprE18 aprE epr bpr mpr ispA [52]
Bacillus subtilis WB800N nprE aprE epr bpr mpr::ble nprB::bsr Δvpr wprA::hyg cm::neo; 
NeoR
[53, 54]
pEJBmD1.3scFv Shuttle vector for the recombinant production and 
secretion of D1.3 scFv in B. megaterium (TcR)
[33]
p3STOP1623hp Shuttle vector for cloning in E. coli (ApR) and production 
of target proteins in B. megaterium (TcR) controlled by 
the optimized xylose-inducible promoter; PxylA
opt-mcs-stop; 
oriU/repU (B. cereus)
[32]
pRBBm117 p3STOP1623hp-derivative: shuttle vector for the 
recombinant production and secretion of D1.3 scFv in 
B. megaterium (TcR) controlled by the optimized xylose-
inducible promoter; PxylA
opt-splipA-d1.3scFv-his6-stop, oriU/
repU (pBC16)
This work
pALBm1 p3STOP1623hp-derivative: shuttle vector for the 
recombinant production and secretion of penicillin 
G acylase in B. megaterium (TcR) controlled by the 
optimized xylose-inducible promoter; PxylA
opt-sppac-pac-
stop, oriU/repU (pBC16)
This work
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transformation of B. subtilis strains DB431 and WB800N 
was prepared from B. subtilis 168 already carrying the 
plasmid pRBBm117. All DNA preparations were done by 
using the QIAgen Spin Miniprep Kit (QIAgen, Hilden, 
Germany) according to the manufacturer’s instruc-
tions with some modifications. For the preparation of 
plasmid DNA from Gram-positive B.  subtilis, lysozyme 
(1  mg  mL−1) was added to the resuspension buffer for 
suspending cells of 50 mL culture (OD600 of 1). Cells were 
then incubated for 10 min at 37 °C before adding the next 
buffer.
The protoplast transformation of B. megaterium 
was performed as outlined previously [82]. The proto-
plast transformation of B. licheniformis was performed 
according to Waschkau et  al. [47]. All B. subtilis strains 
were transformed via induced natural competence. 
For this purpose, cells from a cryogenic glycerol stock 
were grown overnight at 37  °C and 230 min−1 in 10 mL 
competence medium in baffled flasks. The competence 
medium consists of 500 mL L−1 2× SMM (Spizizen min-
imal medium), 5  g  L−1 glucose, 100  mg  L−1 tryptophan, 
1.48 g L−1 MgSO4·7H2O, 200 mg L−1 casamino acids and 
1.1 mg L−1 Fe-NH4-citrate. 2× SMM consists of 4 g L−1 
(NH4)2SO4, 28 g L−1 K2HPO4, 12 g L−1 KH2PO4, 2 g L−1 
Na-citrate·2H2O and 400 mg L−1 MgSO4·7H2O. 10 mL of 
fresh competence medium in a 100 mL baffled flask were 
inoculated with 600  µL of the overnight culture. Cells 
were grown for 3 h at 37 °C and 230 min−1 before 10 mL 
of pre-warmed starvation medium (500 mL L−1 2× SMM, 
5 g L−1 glucose, 1.48 g L−1 MgSO4·7H2O and 1.1 mg L−1 
Fe-NH4-citrate) were added. After another 2 h of incuba-
tion under same conditions, 400 µL of the cell suspension 
were mixed with 1 µg of corresponding plasmid DNA and 
incubated for 1 h at 1000 min−1 and 37 °C. Finally, 100 µL 
were plated on LB agar with 10 mg L−1 of tetracycline and 
incubated overnight at 37 °C.
All strains were stored at −80 °C in a 30% (v/v) glycerol 
solution in cryogenic vials. For preparing cryogenic cul-
tures, 50 mL of LB medium [81] with 10 mg L−1 of tet-
racycline for plasmid-carrying recombinant strains were 
inoculated with cell material from a LB agar plate and 
incubated at 37  °C and 230  min−1. During exponential 
phase (OD600 = 1–2), 32.5 mL of the cell suspension were 
mixed with 17.5 mL of glycerol [86% (v/v)], immediately 
frozen in 1 mL aliquots in liquid nitrogen and stored at 
−80 °C.
Cultivation of recombinant strains
The minimal medium used in this study for production 
of recombinant D1.3 scFv contained 5 g L−1 d-fructose, 
25  g  L−1 (NH4)2SO4, 300  mg  L−1  MgSO4·7H2O, 
3.52  g  L−1 KH2PO4, 5.3  g  L−1 Na2HPO4, 10  mg  L−1 
of tetracycline and 2  mL  L−1 trace element solution. 
For all B. subtilis strains, 16  mg  L−1 tryptophan and 
7.36 g L−1 glutamic acid were added. The trace element 
solution contained 424  mg MnCl2·4H2O, 678.4  mg 
CaCl2·4H2O, 16.8 mg FeSO4·4H2O, 1.4 mg CoCl2, 0.4 mg 
CuSO4·4H2O, 6.2 mg H3BO3, 1.25 mg ZnSO4·7H2O and 
2.6 mg (NH4)6Mo7O24·4H2O per liter. For 100 mL of pre-
cultures, an adequate amount of cryogenic culture was 
used as inoculum (100 µL for B. megaterium, 250 µL for 
B. licheniformis, 50 µL for B. subtilis 168 and DB431 and 
150 µL for B. subtilis WB800N). These pre-cultures were 
grown in 500 mL baffled flasks at 37 °C and 130 min−1 for 
18  h. Main cultures were inoculated with a pre-culture 
volume adjusting to an OD600 of 0.1. Inoculation culture 
was centrifuged (1500×g, 5  min, room temperature) 
before suspended in fresh minimal medium. Expression 
of the D1.3 scFv was induced by addition of 5  g  L−1 
d-xylose at an OD600 of 0.3–0.4.
For shake flasks cultivation for production of recombi-
nant D1.3 scFv, 150 mL of minimal medium were incu-
bated in 500  mL baffled flasks (3  baffles) at 37  °C and 
130 min−1 (50 mm orbital shaking diameter). Shake flask 
cultivations were carried out in triplicate. For bioreac-
tor cultivation, 3 L bioreactors (Applikon, Schiedam, The 
Netherlands) with two six-bladed Rushton turbine impel-
lers were used. Cultivation was performed with 2  L of 
minimal medium. Temperature (37  ±  0.1  °C), aeration 
rate (3.0 L min−1, 1.5 vvm), agitation speed (500 min−1) 
and pH value (pH 6.5 ± 0.1, adjusted with 2 M HCl and 
2 M NaOH) were automatically kept constant. Dissolved 
oxygen (DO) was measured online. Bioreactor cultiva-
tions were carried out in duplicate (strains MS941, MW3, 
168) and triplicate (strains DB431, WB800N), respec-
tively. To prevent foam formation, anti-foaming agent 
(Ucolub®, FRAGOL GmbH & Co. KG, Mühlheim/Ruhr, 
Germany) was added when required. For microtiter plate 
cultivation, 1250 µL of minimal medium was transferred 
to each well of a 48 Well FlowerPlate® (m2p-labs, Baes-
weiler, Germany) with optodes for pH and DO. Plates 
were covered with an adhesive gas-permeable membrane 
(Thermo Scientific, Dreieich, Germany) and incubated 
in a BioLector® unit (m2p-labs, Baesweiler, Germany) at 
37  °C and 1000  min−1 with an orbital shaking diameter 
of 3 mm. The calibration values for the measurement of 
pH and DO were obtained from calibration data sheets 
provided by m2p-labs. According to manufacturer (m2p-
labs, Baesweiler, Germany), the oxygen transfer rate in 48 
Well FlowerPlates® comes to 35–40 mmol L−1 h−1 for the 
used conditions (see above).
Samples of cultivation supernatant were taken for 
HPLC analysis (fructose, xylose and acetate) as well as 
for quantitative ELISA test (D1.3 scFv) as described 
below. For this, cell suspension (1–2 mL) was centrifuged 
at 9000×g, 5  min, 4  °C. Sterile filtered (polyvinylidene 
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fluoride, 0.2  μm pore size, Roth, Karlsruhe, Germany) 
supernatant was stored at −20 °C.
Cultivation of all plasmid strains for the secretion of 
recombinant penicillin G acylase was performed in shake 
flasks as described for the production of D1.3 scFv above 
but took place in LB medium [81]. Main cultivations 
were performed in duplicates. Samples of cultivation 
supernatant were taken for penicillin G acylase activity 
assay as described below. For this, 1 mL cell suspension 
was centrifuged (9000×g, 5 min, 4  °C), supernatant was 
filtered (polyvinylidene fluoride, 0.2 μm pore size, Roth, 
Karlsruhe, Germany) and stored at 4 °C before use.
OD600 and cell dry weight
Cell concentration was determined as optical density at 
a wavelength of 600  nm using a Libra S11 Visible Spec-
trophotometer (Biochrom GmbH, Berlin, Germany). Cell 
dry weight (CDW) was measured via gravimetric analy-
sis. Here, 20 mL culture volume (duplicate) were pelleted 
(1500×g, 15 min, 4 °C) in Corex glass tubes, washed twice 
with distilled water to remove salts and dried at 80  °C 
for 48 h. The relationship between CDW and OD600 was 
determined as CDW [g L−1] = a [g L−1] · OD600 [–] with 
coefficient a equals 0.223 ±  0.007  g  L−1 (B. megaterium 
MS941), 0.40  ±  0.01  g  L−1 (B. licheniformis MW3) and 
0.337  ±  0.002  g  L−1 (all B. subtilis strains used in this 
study), respectively.
High performance liquid chromatography (HPLC) analysis
Sugars (xylose, fructose) were quantified by an HPLC 
system (HitachiElite LaChrom, Krefeld, Germany) 
equipped with a Metacarb 87  °C column (Varian, Palo 
Alto, CA, USA) as stationary phase and Millipore H2O as 
mobile phase at 0.6 mL min−1 and 85 °C with a retention 
time of approximately 11.7  min (xylose) and 13.4  min 
(fructose). Detection was performed using a refractive 
index detector (RI) detector. Acetate were also measured 
using an HPLC system (Hitachi Elite LaChrom, Krefeld, 
Germany) equipped with an Aminex HPX 87 H column 
(Biorad, Hercules, CA, USA) as the stationary phase and 
12.5  mM H2SO4 as mobile phase at 0.5  mL  min−1 and 
45  °C with a retention time of approximately 18.5  min. 
Detection was performed using a RI detector.
Enzyme‑linked immunosorbent assay (ELISA)
ELISA was used to quantify recombinant D1.3 scFv in the 
culture supernatant. Nunc MaxiSorp® flat-bottom 96 well 
plates (Nunc, Wiesbaden, Germany) were coated with 
100 µL of 10 mg L−1 hen egg white lysozyme in PBS buffer 
(145  mM NaCl, 7.5  mM Na2HPO4·2H2O and 2.2  mM 
NaH2PO4·2H2O) per well overnight at 4 °C. Coated wells 
were washed three times with 100  µL of PBS-T 0.05% 
[0.05% (v/v) Tween 20 in PBS] and blocked with 2 g L−1 
skim milk powder in PBS-T 0.1% [0.1% (v/v) Tween 20 
in PBS] for 1.5  h, followed by three times washing with 
100 µL PBS-T 0.05%. Samples of 100 µL were incubated 
for 1.5  h, followed by three times washing with 100  µL 
of PBS-T 0.05%. Detection was performed with 100  µL 
of monoclonal Mouse anti penta His HRP conjugate 
(0.1  ng  µL−1 in PBS-T 0.1%) and visualized with 100  μL 
of tetramethylbenzidine (TMB) substrate solution. Sub-
strate solution consisted of 10  parts of TMB-A solution 
(3  mM H2O2 and 200  mM potassium citrate at pH 4) 
and 0.5 parts of TMB-B solution (41 mM 3,3′,5,5′-tetra-
methylbenzidine in DMSO). The staining reaction was 
stopped by adding 100  μL of 1  M H2SO4. The absorb-
ance at 450 nm and scattered light at 620 nm were meas-
ured using a microtiter plate reader (SUNRISE, Tecan, 
Crailsheim, Germany). The absorbance at 620  nm was 
subtracted.
On each plate, a calibration standard of purified D1.3 
scFv was applied. Standards were purified from culture 
supernatant with immobilized metal affinity chromatog-
raphy (IMAC) and quantified by densiotometric analysis 
as described below. Samples for ELISA were measured in 
adequate dilutions (with PBS) and quantified according 
to the standard via five-parameter logistic analysis.
Penicillin G acylase activity assay
100  µL of substrate solution (0.6  g  L−1 of synthetic 
substrate 2-nitro-5-[(phenylacetyl)amino]-benzoic acid, 
9.41  mM NaH2PO4, 40.59  mM Na2HPO4, pH 7.5) were 
added into a QS ultra-micro cuvette (10 mm light pass; 
Hellma Analytics, Müllheim, Germany) in a tempered 
(37  °C) cuvette holder of an UV–Vis spectrometer 
(Jasco V-650, Jasco, Groß-Umstadt, Germany). 
Addition of 11.11  µL of pre-warmed (37  °C) cell-free 
supernatant started the enzymatic reaction to 2-nitro-
5-aminobenzoic acid, absorbing at 405  nm (extinction 
coefficient ε of 8.98 cm2 µmol−1). Change of absorption 
dA/dt [min−1] at 405 nm was measured every second for 
1  min and was used to calculate enzymatic activity EA 
[µmol cm−3 min−1]
where, VR is the reaction volume [cm3], VE the sample 
volume [cm3] and d equals the light pass [mm]. Enzyme 
activity was expressed in U mL−1 with one Unit U equals 
the enzyme amount to convert 1  µmol of 2-nitro-5-
[(phenylacetyl)amino]-benzoic acid per minute at 37 °C.
EA =
dA
dt
· VR
ε · d · VE
;
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Immobilized metal affinity chromatography (IMAC), 
sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS‑PAGE) and densiotometric analysis
Recombinant D1.3 scFv was purified via IMAC. For this pur-
pose a gravity flow column (BIORAD, Hercules, California, 
USA) was loaded with 1 mL Chelating Sepharose Fast Flow 
(Amersham Biosciences, Freiburg, Germany), washed with 
10 mL H2O, incubated with 2 mL 100 mM NiSO4 for 10 min 
and washed with 5 mL H2O followed by 5 mL washing buffer 
(50 mM NaCl, 20 mM Tris–HCl pH 8.6). The nickel charged 
Sepharose was transferred to 50–100 mL of culture superna-
tant containing 7 mM of imidazole and mixed for 90 min at 
4 °C. The Sepharose was pelleted by centrifugation (1500×g, 
5 min, 4 °C) and washed with 3 mL washing buffer. Elution 
was performed with 3 × 1 mL elution buffer (50 mM EDTA 
in washing buffer). 18 µL of each fractions were analyzed by 
SDS-PAGE analysis (12% of acrylamide) as described before 
[83]. Gels were stained with SimplyBlue™ SafeStain accord-
ing to the manufacturer’s instructions for the microwave 
procedure (Thermo Fisher Scientific Inc., Waltham, Mas-
sachusetts, USA). Band visible on the stained SDS PAGE 
corresponding to recombinant D1.3 scFv in the elution frac-
tions from IMAC were quantified by densitometric analysis 
(ImageJ 1.48v, National Institute of Health, Bethesda, USA) 
related to a BSA standard (10–100 mg L−1).
Precipitation of extracellular proteins
Extracellular proteins of B. megaterium and B. subtilis 
strains cultivated in shake flasks were precipitated by 
incubating 1.5  mL culture supernatant with 660  mg 
(NH4)2SO4 for 2  h at 4  °C in an overhead shaker. After 
centrifugation (9000×g, 30  min, 4  °C), precipitated 
proteins were suspended in 80  µL of 8  M urea 
supplemented with 27 µL of 4-times SDS loading buffer. 
15 µL of this were analyzed by SDS-PAGE as described 
above.
Determination of the volumetric mass transfer coefficient 
(kLa) in bioreactors
kLa value in bioreactors was determined with sulfite oxi-
dation method, which based on oxidation of Na2SO3 to 
Na2SO4 by oxygen. Measurement was performed under 
cultivation conditions (described above) without cells. 
40 mg L−1 of Co(NO3)2 were added as catalyst. DO was 
monitored online with an oxygen sensor (Visiferm DO 
225, Hamilton, Höchst im Odenwald, Deutschland). Cal-
ibration to 100% was performed under oxygen saturation 
condition (DOmax  =  6.784  mg  L−1 at 37  °C). Complete 
oxygen depletion was achieved by addition of 10 mL of a 
200 g L−1 Na2SO3 stock solution [84]. As soon as the oxi-
dation was completed the DO increased again. Plotting 
ln(DOmax − DO) against time, the linear slope was used 
to determine the kLa value.
Kinetics analysis of D1.3 scFv production
The Luedeking–Piret model was used for modeling the 
D1.3 scFv production and secretion [85]. The observed 
experimental product profile from cultivation start to 
the time point of maximal D1.3 scFv concentration 
was approximated by the numerical integration of the 
Luedeking–Piret equation
here, tn and tn − 1 are the present and previous time steps 
of integration. Pn and Pn  −  1 are concentrations of the 
product D1.3 scFv and Xn and Xn − 1 the cell dry weights 
at the present and previous time steps. The growth-
associated Luedeking–Piret constant α [mgscFv g−1cells
] equals the biomass-related product yield coefficient 
YP/X for D1.3 scFv formation. The non-growth-associ-
ated Luedeking–Piret constant β [mgscFv g−1cells h
−1] rep-
resents the specific production rate for specific growth 
rate µ  =  0  h−1. These biological reaction parameters 
were set so that the coefficient of determination R2 was 
maximal, representing the goodness of fit of the model 
concentrations of D1.3 scFv compared to the experi-
mental concentrations. Calculation was performed with 
the Generalized Reduced Gradient algorithm of the add-
in program Solver for Microsoft Excel 2010 (Microsoft, 
Redmund, WA, USA).
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